Limits...
Epidemiology and cost analysis for patients with oral cancer in a university hospital in China.

Han S, Chen Y, Ge X, Zhang M, Wang J, Zhao Q, He J, Wang Z - BMC Public Health (2010)

Bottom Line: Medical hospitalization days (MHD) and cost per patient (CPP) of the samples have been calculated for different patient groups, and the results have been compared using statistical methods.Rural patients were significantly younger than urban patients.Lack of medicare, smoking habit, late clinical stage and SCC are the high economic factors for patient medical cost.

View Article: PubMed Central - HTML - PubMed

Affiliation: Administration of Clinical Research and Teaching, School of Stomatology, the Fourth Military Medical University, Xi'an PR China.

ABSTRACT

Background: Although several studies have reported the direct cost of oral cancer (OC), little research has invested the factors that could influence the costs of OC patient. This study analyzes the epidemiological characteristics and the direct cost of OC. More specifically, the study examines the relationship between patients' medical costs and influencing factors of epidemiology.

Methods: All patients encountered from January 2007 to December 2007 at the School of Stomatology of the Fourth Military Medical University (FMMU) in China with diagnosis of oral cancer have been selected. Medical hospitalization days (MHD) and cost per patient (CPP) of the samples have been calculated for different patient groups, and the results have been compared using statistical methods.

Results: A total of 456 oral cancer patients have been selected in this study. The epidemical characteristics are as follows: female/male 176/280; squamous cell carcinoma (SCC)/adenocarcinoma/sarcoma/lymphoma/other types 246/127/40/27/16; stage I/II/III/IV 90/148/103/115; smoker/non-smoker 136/320; rural/urban patients 82/374. Of all the patients, 82.24% were over 40 years of age. Rural patients were significantly younger than urban patients. SCC was the majority histology in older patients, while sarcoma was more common in younger patients. 372 of the patients received treatment and 84 gave up any treatment after diagnosis. Treatment cost accounted for majority of the payment. The CPP and MHD of patients in late clinical stage were higher than that of patient in early stage.

Conclusion: Gender, smoking habit and age older than 40 years are the epidemiological risk factors for oral cancer. Lack of medicare, smoking habit, late clinical stage and SCC are the high economic factors for patient medical cost.

Show MeSH

Related in: MedlinePlus

proportion of smoking patient in the sample. Figure 2A pathology distribution in the total sample and smoker group respectively. Figure 2B clinical stage distribution proportion in the smoker group.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC2864212&req=5

Figure 2: proportion of smoking patient in the sample. Figure 2A pathology distribution in the total sample and smoker group respectively. Figure 2B clinical stage distribution proportion in the smoker group.

Mentions: As tobacco smoking is the most important risk factor for oral cancer, the pathology distribution was examined in the total sample and smoker group respectively (Figure 2). Compared with the total sample, the proportion of SCC in smoker group was relatively high compared with other the non-smoker samples (69.85% vs. 53.95%), while adenocarcinoma, lymphoma and sarcoma shared the low proportions (17.65% vs. 27.85%; 3.68% vs. 5.92%; 5.14% vs. 8.77% respectively) (figure 2A). Table 2 showed that the proportion of male smokers in late stage (III and IV) was evidently higher than that in early stages (I and II) (figure 2B) and the proportion of male smoker with SCC was evidently higher than that with adenocarcinoma.


Epidemiology and cost analysis for patients with oral cancer in a university hospital in China.

Han S, Chen Y, Ge X, Zhang M, Wang J, Zhao Q, He J, Wang Z - BMC Public Health (2010)

proportion of smoking patient in the sample. Figure 2A pathology distribution in the total sample and smoker group respectively. Figure 2B clinical stage distribution proportion in the smoker group.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC2864212&req=5

Figure 2: proportion of smoking patient in the sample. Figure 2A pathology distribution in the total sample and smoker group respectively. Figure 2B clinical stage distribution proportion in the smoker group.
Mentions: As tobacco smoking is the most important risk factor for oral cancer, the pathology distribution was examined in the total sample and smoker group respectively (Figure 2). Compared with the total sample, the proportion of SCC in smoker group was relatively high compared with other the non-smoker samples (69.85% vs. 53.95%), while adenocarcinoma, lymphoma and sarcoma shared the low proportions (17.65% vs. 27.85%; 3.68% vs. 5.92%; 5.14% vs. 8.77% respectively) (figure 2A). Table 2 showed that the proportion of male smokers in late stage (III and IV) was evidently higher than that in early stages (I and II) (figure 2B) and the proportion of male smoker with SCC was evidently higher than that with adenocarcinoma.

Bottom Line: Medical hospitalization days (MHD) and cost per patient (CPP) of the samples have been calculated for different patient groups, and the results have been compared using statistical methods.Rural patients were significantly younger than urban patients.Lack of medicare, smoking habit, late clinical stage and SCC are the high economic factors for patient medical cost.

View Article: PubMed Central - HTML - PubMed

Affiliation: Administration of Clinical Research and Teaching, School of Stomatology, the Fourth Military Medical University, Xi'an PR China.

ABSTRACT

Background: Although several studies have reported the direct cost of oral cancer (OC), little research has invested the factors that could influence the costs of OC patient. This study analyzes the epidemiological characteristics and the direct cost of OC. More specifically, the study examines the relationship between patients' medical costs and influencing factors of epidemiology.

Methods: All patients encountered from January 2007 to December 2007 at the School of Stomatology of the Fourth Military Medical University (FMMU) in China with diagnosis of oral cancer have been selected. Medical hospitalization days (MHD) and cost per patient (CPP) of the samples have been calculated for different patient groups, and the results have been compared using statistical methods.

Results: A total of 456 oral cancer patients have been selected in this study. The epidemical characteristics are as follows: female/male 176/280; squamous cell carcinoma (SCC)/adenocarcinoma/sarcoma/lymphoma/other types 246/127/40/27/16; stage I/II/III/IV 90/148/103/115; smoker/non-smoker 136/320; rural/urban patients 82/374. Of all the patients, 82.24% were over 40 years of age. Rural patients were significantly younger than urban patients. SCC was the majority histology in older patients, while sarcoma was more common in younger patients. 372 of the patients received treatment and 84 gave up any treatment after diagnosis. Treatment cost accounted for majority of the payment. The CPP and MHD of patients in late clinical stage were higher than that of patient in early stage.

Conclusion: Gender, smoking habit and age older than 40 years are the epidemiological risk factors for oral cancer. Lack of medicare, smoking habit, late clinical stage and SCC are the high economic factors for patient medical cost.

Show MeSH
Related in: MedlinePlus